Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | -5.3% | -0.4% | 2.2% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 15.9% | 28.8% | 22.6% | 24.8% |
| R&D Expenses | $4 | $4 | $4 | $5 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $6 | $5 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $9 | $9 | $11 |
| Operating Income | -$8 | -$9 | -$9 | -$10 |
| % Margin | -281.7% | -289.7% | -288.2% | -347.7% |
| Other Income/Exp. Net | -$2 | -$6 | -$3 | -$4 |
| Pre-Tax Income | -$10 | -$15 | -$12 | -$14 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$10 | -$15 | -$12 | -$14 |
| % Margin | -340.5% | -492.1% | -388.1% | -487.2% |
| EPS | -0.38 | -0.59 | -0.5 | -0.74 |
| % Growth | 35.6% | -18% | 32.4% | – |
| EPS Diluted | -0.38 | -0.59 | -0.5 | -0.74 |
| Weighted Avg Shares Out | 23 | 25 | 23 | 19 |
| Weighted Avg Shares Out Dil | 23 | 25 | 23 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $4 | $3 | $2 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$4 | -$10 | -$8 | -$11 |
| % Margin | -154.9% | -341.8% | -272% | -373.9% |